对肿瘤免疫治疗新方法的兴趣已促使一些生物制品,诸如干扰素和胸腺激素商品化的开发以及许多具有免疫调节性质的化合物的化学合成。这些免疫调节剂已试验性地应用于一些疾病中,它们包括急性和慢性的病 Interest in new approaches to tumor immunotherapy has led to the development of the commercialization of certain biologicals, such as interferons and thymus hormones, as well as the chemical synthesis of many immunomodulatory compounds. These immunomodulators have been used tentatively in a number of diseases, including acute and chronic diseases